Cumulative Corticosteroid Dose Over Fifty‐Two Weeks in Patients With Systemic Lupus Erythematosus: Pooled Analyses From the Phase III Belimumab Trials

OBJECTIVE: To examine the effects of treatment with belimumab on corticosteroid dose in patients with systemic lupus erythematosus (SLE) over 52 weeks in 2 randomized, controlled trials. METHODS: Data on patients who were taking corticosteroids at baseline in the Study of Belimumab in Subjects with...

Descripción completa

Detalles Bibliográficos
Autores principales: van Vollenhoven, Ronald F., Petri, Michelle, Wallace, Daniel J., Roth, David A., Molta, Charles T., Hammer, Anne E., Tang, Yongqiang, Thompson, April
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Systemic Lupus Erythematosus
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129492/
https://www.ncbi.nlm.nih.gov/pubmed/26992106
http://dx.doi.org/10.1002/art.39682

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129492/
https://www.ncbi.nlm.nih.gov/pubmed/26992106
http://dx.doi.org/10.1002/art.39682

Ejemplares similares